Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA.
Duke University Pratt School of Engineering, Durham, North Carolina, USA.
Otolaryngol Head Neck Surg. 2023 Jul;169(1):76-85. doi: 10.1002/ohn.242. Epub 2023 Jan 29.
To evaluate the effect of a health maintenance reminder (HMR) on human papillomavirus (HPV) vaccine administration and completion across different age, insurance, and race cohorts.
Retrospective pre-post analysis.
Academic primary care.
Patients aged 9 to 26 who had initiated the HPV vaccine series from 2016 to 2021 were analyzed, based on current age-based standards. The cohort was divided based on vaccine uptake before and after the implementation of the HMR program in February 2020. The multivariate analysis estimated the odds of vaccine completion based on sociodemographic factors, and variable interactions were investigated to determine independent associations between sociodemographic factors and HMR implementation.
There were 7654 individual patients (mean age was 15.8 years; 46.7 were males; and 50.7% were white). HPV vaccine completion rates increased post-HMR implementation by 59.2% (37% pre-, and 58.9% post-HMR; p < .001) in the entire cohort. Overall, black patients (adjusted odds ratio [aOR] = 0.68; 95% confidence interval [CI]: 0.60, 0.70) and patients ≥18 years (aOR = 0.13; 95% CI: 0.11, 0.15) were significantly less likely to complete their vaccine series; however, this improved significantly following HMR in these groups (p < .001). Post-HMR, race, and insurance status were not independently associated with disparate vaccine completion rates, however, age was, and patients ≤14 or younger had higher odds of vaccine completion (aOR = 3.54; 95% CI: 2.91, 4.32).
The implementation of an HMR was associated with increased HPV vaccine uptake across age and race groups in this single-institution study. Future research should explore barriers to implementing HMRs in different health care settings.
评估健康维护提醒(HMR)对不同年龄、保险和种族群体中人类乳头瘤病毒(HPV)疫苗接种和完成的效果。
回顾性前后分析。
学术初级保健。
根据当前基于年龄的标准,分析了 2016 年至 2021 年期间开始接种 HPV 疫苗系列的 9 至 26 岁患者。该队列根据 2020 年 2 月实施 HMR 计划前后的疫苗接种情况进行划分。多变量分析根据社会人口统计学因素估计疫苗完成的几率,并调查变量相互作用,以确定社会人口统计学因素与 HMR 实施之间的独立关联。
共有 7654 名个体患者(平均年龄为 15.8 岁;46.7%为男性;50.7%为白人)。HPV 疫苗完成率在实施 HMR 后增加了 59.2%(37%之前,58.9%之后;p < .001)在整个队列中。总体而言,黑人患者(调整后的优势比[aOR] = 0.68;95%置信区间[CI]:0.60,0.70)和≥18 岁的患者(aOR = 0.13;95% CI:0.11,0.15)完成疫苗系列的可能性明显较低;然而,在这些群体中,HMR 后这一情况明显改善(p < .001)。实施 HMR 后,种族和保险状况与不同的疫苗完成率没有独立关联,但年龄是,≤14 岁或更年轻的患者完成疫苗接种的几率更高(aOR = 3.54;95% CI:2.91,4.32)。
在这项单机构研究中,实施 HMR 与不同年龄和种族群体中 HPV 疫苗接种率的提高有关。未来的研究应该探索在不同医疗保健环境中实施 HMR 的障碍。